Home » Topics » BioWorld Science

BioWorld Science
RSS

OR6A2 is a therapeutic target for atherosclerosis, researchers unveil

Feb. 1, 2022

IDE-161 enters IND-enabling studies

Jan. 31, 2022

Improved retinal transplants ready for clinical trials

Jan. 31, 2022

Design of a next-generation cell-based therapy against diabetes

Jan. 31, 2022

ATH-434 demonstrates efficacy in preclinical multiple system atrophy

Jan. 31, 2022

STI-1558 strongly inhibits Omicron variant in cell-based assays

Jan. 31, 2022

New antipsychotic shows partial agonist activity at DRD2/3 and 5-HT1AR with little 5-HT2AR binding

Jan. 31, 2022

Chengdu Fanxi Biopharma identifies PPAR-alpha and/or PPAR-delta agonists

Jan. 31, 2022

Shanghai Institute of Materia Medica patents glucose-lowering agents

Jan. 31, 2022

New IL-17RA antagonists presented by Hitgen

Jan. 31, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...